LeonaBio, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | -17.7% | +21.5% | +27,919.8% | -99.7% | -1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -2.7% | -35.9% | -10.0% | +183.3% | +247.6% | -11.0% | +43.5% | +61.5% | -11.0% | +17.8% | +14.6% | +2.4% | +14.6% | -10.2% | +39.8% | +1.5% | +25.8% | -12.9% | -11.3% | +4.4% | -18.2% | -47.7% | -54.1% | -14.9% | -29.5% | +160.0% | +67.8% | +12.8% | – | |
| – | +0.0% | +48.2% | -9.8% | +47.1% | -14.8% | +172.5% | +148.4% | -14.3% | +38.3% | +54.3% | -13.5% | +44.9% | -1.8% | -18.2% | +7.3% | +10.2% | +18.3% | -21.8% | -11.2% | -7.3% | -8.9% | +28.9% | -18.2% | -15.5% | -30.6% | +11.5% | -7.0% | +82.8% | -4.4% | – | |
| – | +0.0% | +5.5% | -17.0% | +13.4% | +77.7% | +228.5% | +22.7% | +18.7% | +54.3% | +7.1% | +5.3% | +24.5% | +0.8% | +2.4% | +36.4% | -9.6% | +6.3% | +10.8% | -17.2% | -5.4% | +1.2% | +6.6% | -47.4% | -40.3% | -23.7% | -6.5% | +58.0% | +71.0% | +8.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +12.2% | +98.2% | -32.1% | – | – | – | – | – | +100.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.